Multi 12 Urine Drug Test Cup - A New Standard in Drug Testing

Multi 12 Urine Drug Test Cup

Urine drug tests evaluate urine samples to detect the presence of certain illegal drugs and prescription medications. Drug testing is often done as a part of the pre-employment process, during admission in educational institutions and to determine eligibility for participation in sporting events. New point-of-care urine drug test cups provide faster test results in minutes. Lab-based urine drug testing can take longer and is less convenient. The QuikScreen Multi 12 Drug Test Cup is an immune-chromatographic assay for rapid, qualitative detection of drug combinations and their principal metabolites in urine at specified cut-off concentrations. This is an easy, fast, qualitative, visually read competitive binding immunoassay method for screening without the need of instrumentation.

The QuikScreen drug test cup can detect a wide range of drugs of abuse in urine samples (including AMP 1000, BAR 300, BUP 10, BZD 300, COC 300, MAD 300, MDMA 500, MET 1000, OPI 300, OXY 100, PCP 25 and THC 50). The test is a fast, qualitative, visually read, competitive binding immunoassay that employs a unique mixture of antibodies to selectively identify the drugs of abuse and their metabolites with a high degree of sensitivity. Online stores of professional medical lab equipment suppliers offer QuikScreen multi drug test cups in different test panels.

Completely made in USA, these leak-free cups come with the following features:

  • Temperature strip
  • Identification label
  • FDA 510(K) cleared detection strips
  • Easy-to-interpret color bands
  • Built-in test control
  • 18-24 months shelf life
  • Room temperature storage

This self-contained cup does not require any handling or manipulation to activate. The testing process involves just 3 simple steps - urinate into the cup, filling it above the minimum level line, wait 5 minutes, and read the results. Online lab equipment stores offer a QuikScreen configurator that allows customers to adapt and create their own drug test cups.

Abbott Laboratories reaches Agreement to buy Alere for $4.48 Billion